CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphism
Qiang Nie, Xue-ning Yang, She-juan An, Xu-chao Zhang, Jin-ji Yang, Wen-zhao Zhong, Ri-qiang Liao, Zhi-hong Chen, Jian Su, Zhi Xie, Yi-long WuТом:
47
Рік:
2011
Мова:
english
Сторінки:
1971
DOI:
10.1016/j.ejca.2011.04.018
Файл:
PDF, 289 KB
english, 2011